15:02:50 EDT Sat 20 Apr 2024
Enter Symbol
or Name

Login ID:

News for U:HSCS from 2023-04-20 to 2024-04-19 - 31 items News ReleasesIn The NewsOther CAUS
2024-04-02 16:15U:HSCSNews ReleaseHeartSciences to Present at the LD Micro Invitational XIV Conference
2024-03-26 09:00U:HSCSNews ReleaseHeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista(TM) Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients
2024-03-14 16:15U:HSCSNews ReleaseHeartSciences Reports Third Quarter Fiscal 2024 Financial Results
2024-03-12 09:00U:HSCSNews ReleaseHeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista(TM) Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes
2024-03-06 09:00U:HSCSNews ReleaseHeartSciences Announces Canada Patent Grant Covering MyoVista(TM) Wavelet Technology
2024-02-26 09:00U:HSCSNews ReleaseHeartSciences Adds Key Advisor to its Scientific Advisory Board
2024-02-12 09:00U:HSCSNews ReleaseHeartSciences Expands its Scientific Advisory Board
2024-02-01 09:00U:HSCSNews ReleaseHeartSciences Appoints New Scientific Advisory Board Member
2024-01-18 08:00U:HSCSNews ReleaseHeartSciences Announces Results and Adjournment of Annual Shareholder Meeting
2024-01-03 16:15U:HSCSNews ReleaseHeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting
2023-12-14 16:15U:HSCSNews ReleaseHeartSciences Reports Second Quarter Fiscal 2024 Financial Results
2023-12-05 08:00U:HSCSNews ReleaseHeartSciences Receives FDA Confirmation for 510(k) Clearance Pathway
2023-11-20 08:00U:HSCSNews ReleaseHeartSciences Announces Closing of License Agreements with the Icahn School of Medicine at Mount Sinai to Develop and Commercialize AI Cardiovascular Algorithms
2023-11-13 08:45U:HSCSNews ReleaseHeartSciences ¢ € ™ MyoVista ‚ ® wavECGTM Selected for Heart Screening of Irish Garda National Police Officers
2023-10-19 09:00U:HSCSNews ReleaseHeartSciences Issues Investor Update Highlighting Recent Key Achievements and Positive Developments
2023-09-26 08:00U:HSCSNews ReleaseHeartSciences Receives Two New Patent Allowances, Expanding its International Patent Portfolio
2023-09-25 08:00U:HSCSNews ReleaseHeartSciences to Participate in the Maxim Group Virtual Tech Conference Series: Emerging Growth in A.I.
2023-09-21 08:00U:HSCSNews ReleaseHeartSciences Signs Definitive Agreements with the Icahn School of Medicine at Mount Sinai to Commercialize Artificial Intelligence Cardiovascular Algorithms
2023-09-14 16:15U:HSCSNews ReleaseHeartSciences Reports First Quarter Fiscal 2024 Financial Results
2023-09-12 16:15U:HSCSNews ReleaseHeartSciences to Present at the Gilmartin Group Emerging Growth Showcase
2023-09-11 16:15U:HSCSNews ReleaseHeartSciences Named Electrocardiography Advancement Specialists of the Year 2023 - USA in the Global Health & Pharma Excellence Awards
2023-09-07 09:00U:HSCSNews ReleaseHeartSciences Signs Distribution Agreement with MedPhy Technologies, Mumbai, India
2023-08-31 09:00U:HSCSNews ReleaseHeartSciences Signs Distribution Agreement with FJ Medical, Denmark
2023-08-24 09:00U:HSCSNews ReleaseHeartSciences ¢ € ™ MyoVista ‚ ® wavECGTM Selected to be used in Irish Heart Screening Evaluation
2023-08-17 09:00U:HSCSNews ReleaseHeartSciences Announces Further Expansion of Artificial Intelligence (AI) Patent Portfolio
2023-07-27 09:00U:HSCSNews ReleaseMyoVista wavECG goes into clinical use at the Naya Imaging Center in Denmark
2023-07-19 09:00U:HSCSNews ReleaseHeartSciences Provides Business Update and Reports Fiscal 2023 Financial Results
2023-05-17 08:00U:HSCSNews ReleaseHeartSciences Named as a Top 10 Healthcare Artificial Intelligence Solutions Provider 2023 by Healthcare Tech Outlook Magazine
2023-05-09 08:15U:HSCSNews ReleaseHeartSciences Announces Completion of Patient Enrollment for FDA Pivotal Study of MyoVista wavECG
2023-05-08 08:15U:HSCSNews ReleaseHeartSciences to Participate at the Inaugural EF Hutton Global Conference
2023-05-02 08:15U:HSCSNews ReleaseHeartSciences to Participate in The Benchmark Company ¢ € ™s Virtual Individual Investor Healthcare Conference